DIMITROS LIZOS,SVEN WEILER,NIKOLAUS JOHANNES STIEFL
申请号：
BRPI0813625
公开号：
BRPI0813625A2
申请日:
2008.07.24
申请国别(地区):
BR
年份:
2014
代理人:
摘要：
Compounds of formula I in free or salt or solvate form, where R1, R2 and R5 have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
